Aeterna Zentaris (AEZS) raises net proceeds of $12.1M by pricing 11M units at $1.20 each.
Each unit consists of one common share and 0.8 of a warrant to buy one common share at $1.25 each, excercisable for up to five years.
Aeterna Zentaris will use the money to fund its drug development and for general purposes.
Shares are -20.55% at $1.16. (PR)